Davis Selected Advisers lowered its stake in Express Scripts Holding Company (NASDAQ:ESRX) by 5.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,011,191 shares of the company’s stock after selling 246,073 shares during the quarter. Express Scripts Holding comprises approximately 1.1% of Davis Selected Advisers’ investment portfolio, making the stock its 29th biggest holding. Davis Selected Advisers owned 0.69% of Express Scripts Holding worth $256,074,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in ESRX. Pzena Investment Management LLC bought a new position in Express Scripts Holding in the second quarter valued at approximately $181,234,000. Renaissance Technologies LLC lifted its stake in Express Scripts Holding by 9,353.3% in the first quarter. Renaissance Technologies LLC now owns 1,308,239 shares of the company’s stock valued at $86,226,000 after buying an additional 1,294,400 shares in the last quarter. Baupost Group LLC MA bought a new position in Express Scripts Holding in the first quarter valued at approximately $80,978,000. Veritas Asset Management LLP lifted its stake in Express Scripts Holding by 13.2% in the second quarter. Veritas Asset Management LLP now owns 8,192,572 shares of the company’s stock valued at $523,014,000 after buying an additional 952,249 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its stake in Express Scripts Holding by 17.2% in the first quarter. Ameriprise Financial Inc. now owns 5,028,552 shares of the company’s stock valued at $331,430,000 after buying an additional 736,151 shares in the last quarter. 88.69% of the stock is currently owned by hedge funds and other institutional investors.

In other Express Scripts Holding news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the firm’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $63.93, for a total transaction of $249,327.00. Following the transaction, the director now directly owns 11,500 shares in the company, valued at approximately $735,195. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Phyllis S. Anderson sold 578 shares of the firm’s stock in a transaction on Friday, September 8th. The shares were sold at an average price of $63.13, for a total value of $36,489.14. Following the transaction, the vice president now owns 10,530 shares in the company, valued at $664,758.90. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,641 shares of company stock worth $357,317. Company insiders own 0.68% of the company’s stock.

Shares of Express Scripts Holding Company (ESRX) opened at 62.47 on Tuesday. The company has a market capitalization of $36.08 billion, a price-to-earnings ratio of 10.84 and a beta of 0.88. Express Scripts Holding Company has a 52-week low of $57.80 and a 52-week high of $77.50. The firm’s 50-day moving average is $61.81 and its 200 day moving average is $62.96.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.02. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The business had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. During the same period last year, the business earned $1.57 EPS. The business’s revenue was up .5% on a year-over-year basis. On average, equities research analysts anticipate that Express Scripts Holding Company will post $6.99 earnings per share for the current year.

ESRX has been the topic of a number of research reports. ValuEngine lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Robert W. Baird reaffirmed a “hold” rating and issued a $56.00 price target on shares of Express Scripts Holding in a research note on Friday, September 1st. Jefferies Group LLC set a $72.00 price target on shares of Express Scripts Holding and gave the company a “buy” rating in a research note on Tuesday, August 29th. BidaskClub raised shares of Express Scripts Holding from a “sell” rating to a “hold” rating in a research note on Saturday, June 17th. Finally, Needham & Company LLC initiated coverage on shares of Express Scripts Holding in a research note on Friday, July 21st. They issued a “hold” rating on the stock. Four equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Express Scripts Holding currently has a consensus rating of “Hold” and an average target price of $70.09.

ILLEGAL ACTIVITY NOTICE: “Davis Selected Advisers Cuts Holdings in Express Scripts Holding Company (ESRX)” was published by Watch List News and is owned by of Watch List News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.watchlistnews.com/davis-selected-advisers-cuts-holdings-in-express-scripts-holding-company-esrx/1588411.html.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).